NCT04935658

Brief Summary

The aim of the study is to ass wether or not the use of virtual reality during oocyte retrieval provides a better pain relief for patients, compared to a standard analgesic procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

June 9, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 23, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.7 years

First QC Date

May 25, 2021

Last Update Submit

September 3, 2024

Conditions

Keywords

Reproductive Techniques, AssistedOocyte retrievalVirtual realityMedically Assisted ProcreationPainAnalgesia

Outcome Measures

Primary Outcomes (1)

  • Pain during oocyte retrieval, assessed by NRS

    Oral evaluation of pain during the intervention for oocyte retrieval, evaluated by a Numeric Rating Scale (NRS) : from 0 (meaning no pain at all) to 10 (meaning worse pain possible).

    day 0 (During the intervention for oocyte retrieval)

Secondary Outcomes (5)

  • Pain after oocyte retrieval, assessed by NRS

    hour 1 (In the hour following the oocyte retrival)

  • Painkillers consumption during the 48 hours following the oocyte retrieval.

    Day 5

  • Patient satisfaction concerning the use of virtual reality during the oocyte retrieval

    hour 1 (In the hour following the oocyte retrival)

  • Gynaecologist satisfaction concerning the use of virtual reality during the oocyte retrieval

    hour 1 (In the hour following the oocyte retrival)

  • Efficacy of the use of virtual reality during oocyte retrieval

    hour 1 (In the hour following the oocyte retrival)

Study Arms (2)

Virtual Reality Group

EXPERIMENTAL

in this group, patients will use virtual reality during the oocyte retrieval plus the standard anesthesic procedure (local anesthesia)

Device: Hypnotic relaxation induced by virtual reality (device)Drug: local anesthesia

Standard Group

SHAM COMPARATOR

in this group, patients will receive the standard anesthesic procedure during the oocyte retrieval wich is local anesthesia

Drug: local anesthesia

Interventions

A virtual reality device will be install on the patient 3-5 minutes before the beginning of the oocyte retrieval. The device will be wearing by the patient during the entire intervention and 2 minutes after the end of the ponction.

Virtual Reality Group

standard anesthesic procedure

Standard GroupVirtual Reality Group

Eligibility Criteria

Age18 Years - 43 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged between 18 and 43 years
  • First attempt of oocyte retrieval under local anesthesia in the context of a protocol for Medically Assisted Procreation

You may not qualify if:

  • Former attempt of oocyte retrieval
  • Poor oocyte stock : \> 40 years AND low markers (AMH \< 0.5-1.1 ng/ml OR AFC \< 5-7)
  • Unsteady epilepsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, 63000, France

Location

MeSH Terms

Conditions

PainHelping BehaviorAgnosia

Interventions

Anesthesia, Local

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSocial BehaviorBehaviorPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Camille Valdeyron

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: participants receive an intervention throughout the protocol
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

June 23, 2021

Study Start

June 9, 2021

Primary Completion

March 1, 2024

Study Completion

July 1, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations